Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study

Rescue Therapy Using a Rifabutin-Based Regimen is Effective for Cure ofHelicobacter pyloriInfection

(2016) Sander Veldhuyzen van Zanten et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

High-Dose Extended-Release Lansoprazole (Dexlansoprazole) and Amoxicillin Dual Therapy forHelicobacter pyloriInfections

(2014) Taraq A. Attumi et al.   HELICOBACTER

Rifabutin-based High-dose Proton-pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment forHelicobacter pylori

(2014) Hyun Chul Lim et al.   HELICOBACTER

Trends of Second-Line Eradication Therapy forHelicobacter pyloriin Japan: A Multicenter Study in the Tokyo Metropolitan Area

(2013) Daisuke Asaoka et al.   HELICOBACTER

Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection

(2012) Giulia Fiorini et al.   Clinical Gastroenterology and Hepatology

Helicobacter pylori: usefulness of an empirical fourth-line rifabutin-based regimen

(2012) Mario M D'Elios et al.   Expert Review of Gastroenterology & Hepatology

Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

(2011) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Helicobacter pylori Resistance to Rifabutin in the Last 7 Years

(2011) Toshihiro Nishizawa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of Sitafloxacin-Based Rescue Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies

(2011) Juntaro Matsuzaki et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Long-term clinical outcome of gastric MALT lymphoma after eradication ofHelicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan

(2011) Shotaro Nakamura et al.   GUT

Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin

(2010) Makoto Sasaki et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Past Rifampicin Dosing Determines Rifabutin Resistance of Helicobacter pylori

(2009) Shoji Suzuki et al.   DIGESTION

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

(2008) Kazutoshi Fukase et al.   LANCET